Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Doorn, P.A. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(26)
+
-
Availability
Open access
(15)
+
-
Metadata Only
(11)
+
-
Creation Date
2023
(6)
+
-
2022
(5)
+
-
2021
(3)
+
-
2010
(2)
+
-
2018
(2)
+
-
2019
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(22)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(22)
+
-
Scholarly Publications
(4)
+
-
Topic
Covid-19
(5)
+
-
Vaccination
(5)
+
-
Autoimmune disease
(4)
+
-
Disease activity
(4)
+
-
Flare
(4)
+
-
SARS-CoV-2
(4)
+
-
Autoimmune Diseases
(3)
+
-
Guillain-Barre syndrome
(3)
+
-
Antibodies
(2)
+
-
COVID-19
(2)
+
-
Immune-mediated inflammatory diseases
(2)
+
-
Immunity
(2)
+
-
Immunosuppression
(2)
+
-
Pompe disease
(2)
+
-
TNF
(2)
+
-
Tumor Necrosis Factor Inhibitors
(2)
+
-
intravenous immunoglobulin
(2)
+
-
outcome
(2)
+
-
treatment
(2)
+
-
Show more
Author
Doorn, P.A. van
(26)
+
-
Pol, W.L. van der
(13)
+
-
Brusse, E.
(12)
+
-
Eftimov, F.
(12)
+
-
Kooi, A.J. van der
(12)
+
-
Verschuuren, J.J.G.M.
(12)
+
-
Baars, A.E.
(10)
+
-
Boekel, L.
(10)
+
-
Bosma, A.L.
(10)
+
-
Brinke, A. ten
(10)
+
-
Broens, B.
(10)
+
-
Busch, M.H.
(10)
+
-
Goedee, H.S.
(10)
+
-
Ham, S.M. van
(10)
+
-
Jacobs, B.C.
(10)
+
-
Kempen, Z.L.E. van
(10)
+
-
Killestein, J.
(10)
+
-
Leeuw, K. de
(10)
+
-
Ouwerkerk, L. van
(10)
+
-
Raaphorst, J.
(10)
+
-
Ruiter, A.M.
(10)
+
-
Rutgers, A.
(10)
+
-
Sanchez, A.P.
(10)
+
-
Schreurs, C.R.G.
(10)
+
-
Stalman, E.W.
(10)
+
-
Steenhuis, M.
(10)
+
-
Tas, S.W.
(10)
+
-
Verstegen, N.J.M.
(10)
+
-
Volkers, A.G.
(10)
+
-
Wieske, L.
(10)
+
-
Woude, D. van der
(10)
+
-
Cristianawati, O.
(9)
+
-
Els, C.A.C.M. van
(9)
+
-
Jallah, P.B.P.
(9)
+
-
Keijzer, S.
(9)
+
-
Kuijpers, T.W.
(9)
+
-
Teng, Y.K.O.
(9)
+
-
Wit, J. de
(9)
+
-
Bekkenk, M.W.
(8)
+
-
Bemelman, F.J.
(8)
+
-
D'Haens, G.R.A.M.
(8)
+
-
Dam, K.P.J. van
(8)
+
-
Hilhorst, M.L.
(8)
+
-
Musters, A.H.
(8)
+
-
Paassen, P. van
(8)
+
-
Post, N.F.
(8)
+
-
Rispens, T.
(8)
+
-
Spuls, P.I.
(8)
+
-
Takkenberg, R.B.
(8)
+
-
Vegting, Y.
(8)
+
-
Hijnen, D.J.
(7)
+
-
Horvath, B.
(7)
+
-
Kummer, L.Y.L.
(7)
+
-
Lowenberg, M.
(7)
+
-
Keijser, J.B.D.
(6)
+
-
Voskuyl, A.E.
(6)
+
-
Wolbink, G.J.
(6)
+
-
Zwinderman, K.A.H.
(6)
+
-
Allaart, C.F.
(5)
+
-
Allaart, R.C.F.
(5)
+
-
Cornblath, D.R.
(5)
+
-
Faber, C.G.
(4)
+
-
Hughes, R.A.C.
(4)
+
-
Huizinga, R.
(4)
+
-
Verboon, C.
(4)
+
-
Voskuyl, A.
(4)
+
-
Walgaard, C.
(4)
+
-
Wolbink, G.
(4)
+
-
Berg, B. van den
(3)
+
-
Boogaard, A.
(3)
+
-
Engelen, B.G.M. van
(3)
+
-
Fokkink, W.J.R.
(3)
+
-
Gorson, K.C.
(3)
+
-
Harbo, T.
(3)
+
-
Hijnen, D.
(3)
+
-
Horváth, B.
(3)
+
-
IGOS Consortium
(3)
+
-
Keijser, J.
(3)
+
-
Kuitwaard, K.
(3)
+
-
Kuks, J.B.M.
(3)
+
-
Kummer, L.Y.
(3)
+
-
Kusunoki, S.
(3)
+
-
Lingsma, H.F.
(3)
+
-
Löwenberg, M.
(3)
+
-
Rijs, W. van
(3)
+
-
Steyerberg, E.W.
(3)
+
-
T2B Immunity SARS-CoV-2 Study Grp
(3)
+
-
Beek, N.A.M.E. van der
(2)
+
-
Bekkenk, M.H.
(2)
+
-
Bemelman, F.E.
(2)
+
-
Berg, L.H. van den
(2)
+
-
Cavaletti, G.
(2)
+
-
Chavada, G.
(2)
+
-
D'Haens, G.R.A.M.I.
(2)
+
-
Dam, P.J.K. van
(2)
+
-
Doets, A.Y.
(2)
+
-
Dutch GBS Study Grp
(2)
+
-
Galassi, G.
(2)
+
-
Hartung, H.P.
(2)
+
-
Hilhorst, M.
(2)
+
-
Kooi, A. van der
(2)
+
-
Kuijpers, T.
(2)
+
-
Kuwabara, S.
(2)
+
-
Lehmann, H.C.
(2)
+
-
Musters, A.F.
(2)
+
-
Notermans, N.C.
(2)
+
-
Paassen, P.H. van
(2)
+
-
Ploeg, A.T. van der
(2)
+
-
Post, N.L.
(2)
+
-
Reisin, R.C.
(2)
+
-
Rispens, T.W.
(2)
+
-
Roosen, J.
(2)
+
-
Spuls, P.W.
(2)
+
-
T2B Immunity SARS CoV 2 Study Grp
(2)
+
-
TB2 Immunity Sars-Cov-2 Study Grp
(2)
+
-
Takkenberg, B.
(2)
+
-
Tio-Gillen, A.P.
(2)
+
-
Vegting, Y.J.
(2)
+
-
Verschuuren, J.J.G.M.M.
(2)
+
-
Visser, L.H.
(2)
+
-
Show more
Language
en
(26)
+
-
Search results
(1 - 24 of 26)
Pages
1
2
›
››
show grid
show list
save search
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Lysosomal glycogen accumulation in Pompe disease results in disturbed cytoplasmic glycogen metabolism
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
Intravenous immunoglobulin treatment for mild Guillain-Barre syndrome
Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
Pain-related changes in cutaneous innervation of patients suffering from bortezomib-induced, diabetic or chronic idiopathic axonal polyneuropathy
Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barre syndrome
IVIg-induced plasmablasts in patients with Guillain-Barre syndrome
Second IVIg course in Guillain-Barre syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial
Regional variation of Guillain-Barre syndrome
International Guillain-Barre Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barre syndrome
The epidemiology of neuromuscular disorders: Age at onset and gender in the Netherlands
IgG Fc N-Glycosylation in Guillain-Barre Syndrome Treated with Immunoglobulins
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study
Anoctamin 5 mutations in the Dutch limb girdle muscular dystrophy population
Pages
1
2
›
››